Microdosing GLP-1s: what the evidence says, and what it doesn't

What "microdosing" means

There's no single definition. Tufts Medicine says "microdosing" isn't a formal medical term, and that there aren't established clinical guidelines supporting it as a weight-loss strategy. AARP and Tufts describe a few ways people use the word:

• Staying on a very low starting dose long term
• Taking less medicine than a doctor prescribed
• Spacing out injections beyond the recommended interval
• Taking a compounded version at an amount lower than the FDA has approved

The medicines involved are the same ones used for type 2 diabetes and weight management: semaglutide (sold as Ozempic and Wegovy) and tirzepatide (sold as Mounjaro and Zepbound). Cleveland Clinic notes that attention has shifted to microdosing compounded versions of these drugs.

Why people try it

The reasons are understandable. Cleveland Clinic, Tufts and AARP point to the same few:

• Cost. Cleveland Clinic says the main reason is to make the medicine last longer and save money, since most insurance doesn't cover these drugs for weight loss.
• Side effects. Nausea, constipation, reflux and diarrhea are common when starting a GLP-1. Some people hope a lower amount will mean fewer of them.
• Food noise. Tufts says some people want relief from constant thoughts about food more than large weight loss.
• Keeping results. Cleveland Clinic notes that people who stop GLP-1s may regain weight, so some look for a lower-cost way to stay on one.

What the evidence shows

Here's the honest picture from the sources we checked:

• The big trials used standard doses. Tufts says most clinical trials for GLP-1 medicines studied specific dose ranges, and the most significant weight loss happened at full therapeutic doses. AARP says the medicines have only been rigorously studied at standard doses.
• There's no approved microdose. "The FDA has not approved a microdose," a Yale physician told AARP, adding that the evidence for the general population and for older adults is very limited.
• There's no guideline. Cleveland Clinic says there aren't any official or standard guidelines for microdosing, and it isn't endorsed by the American Diabetes Association.
• Lower amounts may not give the same benefits. AARP notes that lowering the dose could reduce other benefits these medicines provide, such as protection for the heart and kidneys. A physician told AARP there's no evidence for social media claims that microdosing reduces inflammation.
• Some people do respond to lower amounts. Tufts says some patients report reduced appetite and quieter food noise at lower doses, and that clinicians sometimes intentionally keep certain patients on lower doses. The open question, Tufts says, is whether those effects are strong enough for long-term health benefits.

The bottom line from the evidence: lower doses aren't proven to work for lasting weight loss, and they aren't proven safe as a do-it-yourself strategy.

Whatever you and your prescriber decide about medicine, daily habits still matter. Olive is a health companion that checks in with you every day, looks at what you eat, and helps you build small habits that actually hold. It doesn't diagnose or treat anything, so dosing questions belong with your prescriber.

The risks

Cleveland Clinic and Tufts describe several risks:

• Side effects that keep coming back. Cleveland Clinic says common side effects like diarrhea, nausea and bloating often ease when the medicine is taken as prescribed. With a reduced amount, a Cleveland Clinic physician explains, the drug may leave your system faster than intended, so side effects can return each time you take it again.
• Measuring mistakes. Cleveland Clinic warns that measuring smaller amounts yourself can lead to errors and accidental overdose, especially with compounded versions, which aren't all concentrated the same way.
• Under-treatment. Tufts lists inconsistent blood sugar control in people with diabetes and under-treatment of obesity-related health conditions as concerns.
• No supervision. Tufts flags using medicine without medical supervision as a risk in itself.

If you're having side effects on a GLP-1, our guide to what to eat when nausea hits may help in the meantime. Tell your prescriber about side effects rather than cutting back on your own.

Compounded GLP-1s and microdosing

Much of the microdosing trend runs through compounded medicines. These are versions mixed by a pharmacy rather than made by the original drug company.

The FDA says compounded drugs aren't FDA approved, which means the agency doesn't review them for safety, effectiveness or quality before they're marketed. It says compounded drugs should only be used when a patient's medical needs can't be met by an FDA-approved drug. Cleveland Clinic says the same about review and quotes an obesity medicine physician who doesn't recommend compounded versions because they're untested.

The FDA also lists red flags for telehealth companies, including a company that:

• Claims a compounded drug is the same as an FDA-approved one
• Offers medicine at prices that seem too good to be true
• Doesn't require a screening and prescription by a licensed doctor
• Has no licensed doctor available to answer questions afterward

Our guide to the compounded GLP-1 recall covers more on what can go wrong with compounded products.

When a lower dose is a medical decision

Lower doses aren't always a bad idea. They're just not a DIY decision. Tufts says clinicians may intentionally keep patients on lower doses if they're very sensitive to side effects, if they see metabolic improvements at lower levels, or if they're coming off the medicine. AARP quotes physicians who say the right dose is chosen for the individual patient.

"We can adjust the dose to the individual needs of each person," a Cleveland Clinic physician says. "And that's not microdosing. That's just the art of practicing medicine."

If you're weighing your options, our guide comparing the Wegovy pill and injection covers another choice to raise with your prescriber.

Questions to ask your prescriber

If you're curious about microdosing, Tufts suggests starting with a conversation with your doctor. Useful questions:

• Is a GLP-1 the right option for me at all, or would lifestyle changes be enough?
• What are my goals: weight, blood sugar, appetite, or food noise?
• If side effects are a problem, what are the approved ways to manage them?
• If cost is the problem, what coverage or lower-cost FDA-approved options exist?
• If I'm using a compounded product, what pharmacy made it, and how do I know it's measured correctly?

For eating well on any GLP-1, our guide to what to eat on Foundayo has practical meal ideas.

This guide is general information, not medical advice. Don't start, stop or change any medicine, or the amount you take, without your prescriber.

Build habits that last

Medicine is one part of the picture. Olive checks in with you every day and helps you build small habits that actually hold, with or without a GLP-1.

See how Olive works →